Search

everythinglearnresearchcommunity

for

Search:↓

Birds can regenerate inner ear cells using specific gene pathways, unlike mammals.

Thyroid function affects skin health, with a complex interaction between the two.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Targeting EGFR may help reduce hair loss from chemotherapy.

Understanding how epigenetic regulation affects stem cells is key to cancer insights and new treatments.

Blocking TSLP reduces skin inflammation and cell overgrowth in psoriasis.

Sorafenib can cause facial acne-like eruptions, which improve after reducing the dose or stopping the drug.

Twist1 helps maintain important features of cells crucial for hair growth by working with Tcf4 and β-catenin.

Finasteride may cause kidney damage.

PGA-4HGF may help treat hair loss by activating hair growth pathways and extending the hair growth phase.

Western diet may cause male pattern baldness; low glycemic diet with magnesium could help.

The research suggests new treatments for skin cancer could target specific cell growth pathways.

iNOS contributes to hair loss in obese diabetic mice and blocking it may encourage hair growth.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

The cornified envelope is crucial for skin's barrier function and involves key proteins and genetic factors.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Cancer treatments often cause hair loss, and more research is needed to prevent and treat it.

Alopecia can often be managed effectively with various treatments, but early diagnosis is crucial for preventing permanent hair loss.

Hair loss can be caused by cancer, treatments, or skin conditions, and trichoscopy helps diagnose it.

Androgenetic alopecia treatments are becoming more personalized and include new therapies like topical antiandrogens and regenerative strategies.

Individualized treatment and psychological support improved the patient's quality of life and appearance despite medication side effects.

An imbalanced scalp microbiome may worsen alopecia areata severity and inflammation, but treatment can partially restore balance.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

Mesenchymal stem cells from laser-assisted liposuction are as effective and safe as those from conventional liposuction for cell therapy.

A device was made in 2008 to measure hair loss severity. Other findings include: frizzy mutation in mice isn't related to Fgfr2, C/EBPx marks preadipocytes, Cyclosporin A speeds up hair growth in mice, blocking plasmin and metalloproteinases hinders healing, hyperbaric oxygen helps ischemic wound healing, amniotic membranes heal wounds better than polyurethane foam, rhVEGF165 from a fibrin matrix improves tissue flap viability and induces VEGF-R2 expression, and bFGF enhances wound healing and reduces scarring in rabbits.

VEGFR-2 activation is likely involved in hair follicle growth, survival, and development.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

Most children with alopecia areata improved with treatment, but those with more hair loss had worse outcomes.